$7.75 $0.15 (2.0%)

04:00 PM EDT on 08/16/19

Prothena Corporation (NASDAQ:PRTA)

CAPS Rating: 3 out of 5

Current Price $7.75 Mkt Cap $356.4M
Open $7.67 P/E Ratio 0.00
Prev. Close $7.60 Div. (Yield) $0.00 (0.0%)
Daily Range $7.64 - $7.84 Volume 136,609
52-Wk Range $7.52 - $14.77 Avg. Daily Vol. 6

Caps

How do you think NASDAQ:PRTA will perform against the market?

Add Stock to CAPS Watchlist

All Players

36 Outperform
7 Underperform
 

All-Star Players

11 Outperform
4 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top NASDAQ:PRTA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted December 06, 2014

Prothena doesn't seem to have impressed the street much with their recent announcement of positive interim data from the phase I/II trial of NEOD001 anti-amyloid mAb for amyloid light chain (AL) amyloidosis. The company reported a 50% cardiac… More

zzlangerhans (99.83)
Submitted October 22, 2013

Prothena has a healthy market cap of 450M despite a very immature pipeline and a questionable therapeutic platform. The company purports to treat amyloidosis and Parkinson's disease with monoclonal antibodies against abnormally folded proteins, but… More

NASDAQ:PRTA VS S&P 500 (SPY)

NASDAQ:PRTA Summary

Fools bullish on NASDAQ:PRTA are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about PRTA.

Recs

0
Member Avatar usubanas (99.61) Submitted: 9/29/2017 10:20:54 AM : Outperform Start Price: $64.24 NASDAQ:PRTA Score: -103.23

Promising Parkinson's trial

Recs

0
Member Avatar nakrak (< 20) Submitted: 4/7/2015 2:27:34 PM : Outperform Start Price: $38.12 NASDAQ:PRTA Score: -118.22

Good pipeline in addition to present outlook of Parkinsons Diseqse

Leaderboard

Find the members with the highest scoring picks in PRTA.

Score Leader

DoubleBagel

DoubleBagel (33.58) Score: +260.28

The Score Leader is the player with the highest score across all their picks in PRTA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Halffrenzy 25.96 2/28/2014 Underperform 5Y $36.79 -78.93% +54.49% +133.43 0 Comment
FunesDMemorious 98.45 11/15/2013 Underperform 5Y $26.88 -71.17% +60.81% +131.98 0 Comment
BINB 88.15 9/17/2013 Underperform 5Y $20.18 -61.59% +68.87% +130.46 0 Comment
biotechf 94.21 2/16/2016 Underperform 5Y $32.69 -76.29% +52.96% +129.26 0 Comment
GreenAB 37.90 3/20/2015 Underperform NS $42.01 -81.55% +37.53% +119.08 0 Comment
TheGreatSatan 100.00 3/27/2019 Underperform 5Y $12.09 -35.90% +2.72% +38.62 0 Comment
sikiliza < 20 5/3/2019 Underperform 5Y $10.44 -25.77% -1.39% +24.38 0 Comment
DeathStock 59.17 5/13/2019 Outperform 5Y $9.93 -21.95% +2.65% -24.61 0 Comment
drugtrader 90.88 9/18/2018 Outperform 5Y $12.60 -38.49% -0.29% -38.21 0 Comment
conliskjr < 20 12/31/2018 Outperform 3Y $10.34 -25.05% +15.70% -40.75 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.43 3/20/2015 Outperform 3W $38.66 -79.95% +37.23% -117.19 0 Comment
TrackWedbush 88.42 6/27/2013 Outperform NS $11.38 -31.90% +79.24% -111.13 0 Comment